Pages
- Home
- MAbInnovation
- Research
- CDI1 – Interdisciplinary innovation
- CDI2 – Bio-clinical interface
- KQ1 – How can target activity be modulated through antibody binding?
- Flagship project KQ4
- Flagship project KQ1-CDI1
- Flagship project KQ2
- Flagship project KQ3
- KQ2 – How can antibody activity be optimised by adjusting format?
- KQ3 – How can antibody efficacy be increased using combinations?
- KQ4 – How can antibody administration be improved?
- Training
- The LabEx
- Health
- Contact us
- Terms and conditions
- Site map
Posts by category
- Category: News
- EUROMABNET 7TH ANTIBODY VALIDATION WORKSHOP AND 13TH MEETING
- Igyxos Initiates Phase 1 Clinical Trials for IGX12: A Breakthrough Treatment for Infertility
- 10TH ANTIBODY INDUSTRIAL SYMPOSIUM: NEW DEVELOPMENTS IN ANTIBODY AND ADOPTIVE CELL THERAPIES
- POST-DOCTORAL POSITIONS: SCIENTISTS IN ANTIBODY
- Call for candidates : Scientist in antibody bioproduction
- MAbBoost: next session on December 2&3, 2021
- ANTIBODY INDUSTRIAL SYMPOSIUM 2022
- MAbImprove reviews the most advanced anti-CoVID-19 monoclonal antibodies
- PhD funding 2021: antibody thesis subjects labeled in Tours and Montpellier
- A MAbImprove team successful in the Gates Foundation Grand Challenge
- MAbBoost: next session on May 5&6, 2021
- A MAbImprove team successful in the INCa-DGOS call!
- Lucie Pellissier awarded with an ERC Starting Grant 2019
- Do not miss the 2ndes Journées of the Antibody Club!
- Questioning the relevance of non-human primates in the preclinical studies of cytolytic antibodies
- 7th AIS: Harnessing the immune system with therapeutic antibodies – June 24&25
- MAbImprove part of the 103 LAbEx selected for a 5-years extension!
- MAbTope: a Method for Improved Epitope Mapping
- Nobel Prize in Medicine 2018
- Nobel Prize in Chemistry 2018
- APRÈS LE DIAGNOSTIC, UNE PISTE DE TRAITEMENT DE LA POLYARTHRITE RHUMATOÏDE: PROJET ATHRITIS R&D
- Allocations doctorales 2016 : Listes des sujets de thèses anticorps
- PhD Project 2014 “Design of a method for in silico maturation of antibodies”
- Category: Events
- ANTIBODY INDUSTRIAL SYMPOSIUM 2024
- From Bench to Biotech: France-Canada perspectives and success stories
- 8th AIS 2020 virtual event: November 23-24th, 2020
- AIS 2018 : TARGETS FOR MABS INNOVATIVE APPROACHES FOR THEIR DISCOVERY & VALIDATION
- MASTER CLASSES DE L’IMMUNOTHÉRAPIE
- Assises 2017: Antibody-Drug Conjugates
- MAbDelivery Industrial Workshop
- industrial workshop
- Antibody Biosimilars, May 28th 2013, Tours, France
- European Congress of Immunology Glasgow, Scotland | 5 – 8 September, 2012
- “Therapeutic Antibodies and Infectious Diseases” Conference, November 20th-22nd in Tours, France
- Category: Press review
- Category: Publications
- Category: Recruitment
- MSCA Doctoral Network Acinetwork Phd Positions
- Development of new immunoconjugates for HER2-positive breast cancers
- 2 Years Post-doctoral fellowship in Montpellier
- PhD Projects 2015
- Call for proposals 2015: New research team & group leader
- PhD Project 2014 “Modulation of the functions of human dendritic cells by Mabs specific of type C lectine receptors “
- PhD Project 2014 “Regulation of FcRn expression during tumorigenesis: Impact in the treatment with therapeutic antibodies”
- PhD Project 2014 “Identification of new targets involved in the Cetuximab molecular mechanism in colorectal cancer”
- PhD Project 2014 “New formats of recombinant antibody libraries”
- PhD Project 2014 “Analysis of isoforms from the tyrosine kinase receptor HER4: towards a therapeutic targeting using isoform-specific antibodies in cancerology”
- PhD project 2014 “Innovative strategies for bioconjugation towards therapeutic and imaging applications”
- Job offer: MAbImprove scientific coordinator
- Call for proposals 2014: New research team & group leader
- IRCM: Postdoctoral proposition
- New research (Cancer) teams in Montpellier (France)
- Post-graduate researcher/postdoctoral position in Tours (GICC/CEPR)
- Category: Research
- Category: Training
Teams/Research groups
- Molecular Neuroendocrinology of Reproduction
- Imaging, Biomarkers and Therapy
- Nutrition Croissance et Cancer
- Polyomaviruses infections biology (BIP)
- Nanomedicine & Nanoprobes
- Lymphocytes differentiation, tolerance and metabolism: basis for immunotherapy
- Pathophysiology and immunotherapy of inflammatory disorders
- Respiratory infection & Immunity
- Neurogenomics and neuronal physiopathology
- Tumor Microenvironment and Resistance to Therapies Lab
- SENSOR : Energy Sensors and reproductive signalisation
- BACFLY
- IMGT®, the international ImMunoGeneTics information system®
- BIOLOGY OF GPCR SIGNALING SYSTEMS
- Biomédicaments antiparasitaires
- Aerosol therapy and biotherapeutics for respiratory diseases
- Proteolytic Mechanisms in Inflammation
- Radiobiology and Targeted Radiotherapy
- Functional screening and targeting in cancer
- Proteases, Microenvironment and Cancer
- Drug resistance and new cancer treatment
- Immunity and Cancer
- Neuroreceptors, dynamics and function
- T2i: Transplantation, Immunology and Inflammation
Platforms
- BIOCUBE Institute
- Médico-économie des anticorps
- Preclinical models platform
- Proteomics Imaging and Molecular Interaction Plateau (PP2I)
- Chemistry-Physics of antibodies
- Montpellier Cancer Institute (ICM)
- Immunovigilance of antibodies
- Small Animal Imaging (Platform IPABS)
- Monitoring centre and Biological follow-up of therapeautic Antibodies (CePiBAc)
- Biological Resource Centre (CRB)
- Clinical Investigation Centre (CIC Tours)
- Clinical Investigation Centre (CIC Montpellier)
- Small Animal Imaging centre (CIPA)
Past events
- 7TH INTERNATIONAL SYMPOSIUM ON KALLIKREINS AND KALLIKREIN-RELATED PEPTIDASES (ISK2017)
- Therapeutic Monoclonal Antibodies for Respiratory Diseases: Current challenges and perspectives
- Therapeutic antibodies and anaphylaxis
- Therapeutic Antibodies and Infectious Diseases
Partnerships
Industrial Workshops
- ANTIBODY INDUSTRIAL SYMPOSIUM 2024
- ANTIBODY INDUSTRIAL SYMPOSIUM 2023
- Antibody industrial symposium AIS2021: digital edition
- AIS 2020: Multispecific Abs, Ab-like molecules and adoptive cell therapy for fighting diseases
- AIS 2019 : Harnessing the immune system with therapeutic antibodies
- Assises 2018 : Targets for Mabs Innovative Approaches for their Discovery & Validation
- Assises 2017: Antibody-Drug Conjugates: Design & Development for Therapy and Imaging in and beyond Cancer
- Assises 2016: Current and next generation Antibody formats
- Assises 2015: MAbDelivery
- Assises 2014 : MAbDosing
- Assises 2013 : Antibody biosimilars